Optimizing Transhumeral Osseointegration Prosthesis Control
Launched by UNIVERSITY OF ALBERTA · Feb 25, 2025
Trial Information
Current as of November 11, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help people who have lost their arm above the elbow (known as transhumeral amputation) regain better control and function of prosthetic devices. Many individuals face challenges with traditional prosthetics, such as discomfort and difficulty controlling the device. This trial focuses on using bone-anchored prostheses (BAPs) combined with a special surgery called Targeted Muscle Reinnervation (TMR) to improve muscle signal training. The goal is to see if these advanced approaches can make it easier for participants to use prostheses in their daily lives.
To be eligible for this trial, individuals must be between 18 and 65 years old, have a scheduled surgery for osseointegration, and have enough shoulder movement and muscle signals to participate in training. Participants will learn how to use their new device and will be monitored over time to evaluate how well it works for them. This trial is an important step in understanding how to improve the lives of those with upper limb loss and enhance their ability to perform everyday activities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Individuals with transhumeral amputation who:
- • 1. are between 18 and 65 years old,
- • 2. have been scheduled to undergo osseointegration by the Alberta Limb Osseointegration Program.
- • 3. demonstrate adequate pain-free shoulder range of motion to perform the required tasks and have potential muscle signals for myoelectric control to be able to undertake the muscle signal training
- • 4. willing to undergo all of the study procedures and follow-up.
- Exclusion Criteria:
- Individuals who:
- • 1. are unable to comply with treatment or follow-up processes,
- • 2. are unable to understand English sufficiently to provide full informed consent.
- • 3. have shoulder pathology on the side of the amputation (arthritis, adhesive capsulitis, chronic rotator cuff, or musculoskeletal dysfunction) that would negatively affect the ability to perform the training and functional assessments,
- • 4. have insufficient muscle signals to operate a myoelectric prosthesis
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported